EFFICACY AND TOXICITY OBSERVED IN MALIGNANT PLEURAL MESOTHELIOMA PATIENTS TREATED IN PHASE I TRIALS AT A SINGLE INSTITUTION

被引：0
|
作者：
Raphael, J. [1 ]
Hollebecque, A. [2 ]
Le Teuff, G. [3 ]
Massard, C. [2 ]
Bahleda, R. [2 ]
Margery, J. [4 ]
Besse, B. [1 ]
Soria, J. [1 ]
Planchard, D. [1 ]
机构：
[1] Inst Gustave Roussy, INSERM, Thorac Grp, U981, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[3] Inst Gustave Roussy, Dept Stat & Epidemiol, Villejuif, France
[4] Percy Hosp, Dept Pulm, Paris, France
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：496 / 496
页数：1
相关论文
共 50 条
  • [1] Efficacy of phase 1 trials in malignant pleural mesothelioma: Description of a series of patients at a single institution
    Raphael, J.
    Le Teuff, G.
    Hollebecque, A.
    Massard, C.
    Bahleda, R.
    Margery, J.
    Besse, B.
    Soria, J. -C.
    Planchard, D.
    LUNG CANCER, 2014, 85 (02) : 251 - 257
  • [2] Nivolumab for Advanced Malignant Pleural Mesothelioma outside of Clinical Trials: A Single Institution Experience
    Zhang, Jun
    Burt, Bryan
    Sena, Maria
    Sugarbaker, David
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1361 - S1362
  • [3] Chemotherapy for malignant pleural mesothelioma - a single institution experience
    Arif, S. S.
    Linnane, S. J.
    Duckers, J.
    Lester, J. F.
    LUNG CANCER, 2009, 63 : S27 - S27
  • [4] Advanced Malignant Pleural Mesothelioma: A Single Institution Experience
    Gutierrez Sainz, L.
    Cruz, P.
    Martinez Recio, S.
    Esteban, I.
    Arias Lotto, F.
    Vinal, D.
    Villamayor, J.
    Sanchez Cabrero, D.
    Higuera, O.
    De Castro Carpeno, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S993 - S994
  • [5] Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study
    Ikeda, Takaya
    Takemoto, Shinnosuke
    Senju, Hiroaki
    Gyotoku, Hiroshi
    Taniguchi, Hirokazu
    Shimada, Midori
    Dotsu, Yosuke
    Umeyama, Yasuhiro
    Tomono, Hiromi
    Kitazaki, Takeshi
    Fukuda, Masaaki
    Soda, Hiroshi
    Yamaguchi, Hiroyuki
    Fukuda, Minoru
    Mukae, Hiroshi
    THORACIC CANCER, 2020, 11 (07) : 1972 - 1978
  • [6] Neo-Adjuvant Immunotherapy in Malignant Pleural Mesothelioma: Report on Three Cases Treated in a Single Institution
    Novellis, P.
    Rossetti, F.
    Di Fonzo, R.
    Muriana, P.
    Lazzari, C.
    Ogliari, F. R.
    Bulotta, A.
    Ferrara, R.
    Gregorc, V.
    Veronesi, G.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S713 - S714
  • [7] Therapies currently in Phase II trials for malignant pleural mesothelioma
    Pinton, Giulia
    Manente, Arcangela Gabriella
    Tavian, Daniela
    Moro, Laura
    Mutti, Luciano
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (10) : 1255 - 1263
  • [8] Surgical therapy of malignant pleural mesothelioma: A single institution's experience
    Van Sandick, J. W.
    Klomp, H. M.
    Van Mourik, J. C.
    Baas, P.
    Belderbos, J. S.
    Zoetmulder, F. A.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 27 - 27
  • [9] Predictors of long-term postoperative survival in malignant pleural mesothelioma: A multivariate analysis in 300 patients treated in a single institution
    Trousse, D. S.
    Nakas, A.
    Edwards, J. G.
    Martin-Ucar, A. E.
    O'Byrne, K. J.
    Waller, D. A.
    THORAX, 2007, 62 : A49 - A50
  • [10] Determinants of survival in patients with malignant pleural mesothelioma (MPM) managed at a single institution in Liguria, Italy
    Carletti, Anna Maria
    Benfatto, Lucia
    Balestracci, Vanna
    Canessa, Pier Aldo
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
12345